Collaboration

To validate the impact of VeraTag™ assays on research and development of pharmaceutical, biotechnology, and diagnostic products as well as to demonstrate their potential for individualized therapeutic selection, Monogram has established agreements with leading companies and collaborations with thought leaders and biomedical research institutes.

In addition, Monogram has strong ties to prestigious medical research centers and renowned cancer organizations exploring the use of the VeraTag System in clinical trials of approved and investigational targeted therapeutics in North America, Europe and Japan. Our goals are to develop intellectual property, support publications in peer-reviewed journals, and provide validating clinical data to support regulatory approvals.

We collaborate with leading research groups, including the following:

• Eastern Cooperative Oncology Group
• Helsinki University Central Hospital
• Jules Bordet Institute, Belgium
• M.D. Anderson Cancer Center
• Mayo Clinic- Rochester, Minnesota
• Mayo Clinic- Jacksonville, Florida
• National Cancer Center Hospital, Japan
• Penn State Milton S. Hershey Medical Center
• Tokyo Metropolitan Institute of Medical Science (Rinshoken), Japan
• University of Miami/Sylvester Comprehensive Cancer Center
• University of Pittsburgh
• University of Southern California/Norris Comprehensive Cancer Center
• Vall D'Hebron University Hospital, Spain
• Vanderbilt University
• Wilshire Oncology Medical Group
• Yale University